LITTLE KNOWN FACTS ABOUT WHAT ARE THE BEST NEUROPROTECTIVE DRUGS?.

Dependant on the subgroup analysis, we identified that there was major heterogeneity with regards to mortality, favorable results, and the overall therapy powerful fee. Regarding mortality, The explanation for heterogeneity to the subgroup of edaravone dexborneol and EDV was mainly attributed to variances in drug dosage. About favorable results, Th